ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$282.79
−0.92%Forward multiples
Based on analyst estimates
- P/E forward
- 18.07x
- P/E 2026E
- 20.34x
- P/E 2027E
- 17.33x
- P/E 2028E
- 15.88x
- P/S forward
- 7.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- 79.67x
- PEG TTM
- 0.23x
- Price / book
- -84.20x
- Price / sales
- 7.76x
- Price / cash flow
- 25.62x
Enterprise value
- Enterprise value
- $564.0B
- EV / sales
- 8.76x
- EV / EBITDA
- 26.63x
- EV / EBIT
- 29.88x
- Market cap
- $499.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026